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Abstract  
Introduction: Epithelial-Mesenchymal Transition in colorectal cancer cell 
is a critical process in which cells lose their epithelial properties and obtain 
mesenchymal characteristics, resulting in tumor cells and metastasis. This 
study attempted to work on the effects of conditioned medium from bone 
marrow-derived mesenchymal stem cells on EMT markers. 
Materials and Methods: In this study, HT29 was used  which is the 
colorectal cancer cell line. Cells were treated for 72 hours with BMSC-CM 
in order to induce EMT in HT29. The Real-Time PCR was used for 
evaluating EMT markers such as E-cadherin- β-catenin -vimentin-and 
transcription factors.  
Results: Inducing EMT in colorectal cancer cells caused morphological 
changes. It was manifested that E-cadherin is downregulated after 
induction of EMT with treated BMSC-CM. On the other hand, there were 
a significant increase in β-catenin, Vimentin, Snail and ZEB1 expression.  
Conclusion: Understanding the molecular basis of tumor metastasis is 
critical for colorectal cancer treatment. Findings demonstrated 
morphological alterations in consequence MSCs-CM activates induction 
of EMT. This process affects EMT markers of E-cadherina, Vimentin, β-
Catenin and transcription factors of Snail and ZEB1. This model helps 
knowing cancer and metastasis pathway and also could be used in drug 
screening procedures.  
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1. Introduction 
     Metastases pose a therapeutic challenge 
for the treatment of colorectal cancer 
(CRC), the third most common cancer and 
the second leading cause of cancer-related 
deaths in the United States, with an 
estimated 140,000 new cases and 51,000 
deaths in 2018 [1]. Approximately 21% of 
CRC patients will have distant metastases 
and, despite favorable results for localized 
and regional diseases (89.8% and 71.1% 
respectively 5-year survival), metastatic 
disease 5-year survival is around 14% [2]. 
However, 50% of metastatic disease 
patients have liver-only disease that can be 
amenable to therapeutic intervention [3]. 
Nevertheless, conventional therapy is not 
appropriate for most metastasized  CRC 
patients [4, 5]. In other words, advanced 
CRC with metastasis does not have an 
effective therapy [6]. To sum up, it is 
important to find new biomarkers for CRC 
diagnosis and establish novel treatment 
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methods [7]. Metastatic cancer development 
involves alterations in epithelial structure 
and function [8]. In other terms, numerous 
studies have shown a direct relationship 
between metastasis and the phenomenon of 
Epithelial-mesenchymal transition (EMT) 
[9]. Recent evidence suggests the epithelial-
mesenchymal transition (EMT) promotes 
migration, invasion, and metastasis of tumor 
cells [10, 11]. It is widely accepted that a 
fundamental process for distant metastasis 
formation is the epithelial-mesenchymal 
transition (EMT), during which tumor cells 
lose their epithelial properties and acquire a 
fibroblast-like phenotype [12, 13] by 
reducing the expression of epithelial 
markers such as E-cadherin and the 
expression of mesenchymal markers such as 
Vimentin [14]. Signals facilitating and 
controlling this process in developmental 
and cancer EMT is derived from a 
microenvironment of the tissue and 
typically function as transcriptional 
repressors. They are also associated with 
zinc-finger factors including Snail1, Snail2 
(Slug), ZEB 1/2 and Twist 1/2 baseline 
helix-loop-helix proteins (bHLH) [15]. 
Conversely, activation of mesenchymal 
genes by Snail factors appears to be 
indirect, at least in part, via downregulation 
of E-cadherin. Whatever their inductive 
effects on ZEB1 and ZEB2, Snail factors 
also regulate epithelial and mesenchymal 
markers directly [16-18]. Indeed, the 
emerging consensus in the literature points 
to Snail1 as the mechanism responsible for 
initiating EMT in reaction to signal 
induction [19, 20]. In addition, EMT is 
linked to a variety of signaling pathways 
including Transforming Growth Factor-β 
(TGF-β), Platelet-Derived Growth Factor 
(PDGF), and Hepatocyte Growth Factor 
(HGF), Notch, and RAS [21]. A large 
number  of  reports represent that cancer 
cells showed the properties of cancer stem 
cells during EMT, and that their gene 
expression profile is approximately similar 
to cancer stem cells [22]. Mesenchymal 
stem cells (MSCs) are adult stem cells 
which can be isolated from post-natal tissue. 
MSCs are multipotent cells that can divide 
into three germ layer-lineages, including 
osteoblasts, adipocytes and chondrocytes, 
known as the mesodermal lineage [23]. 
MSCs also have the capacity for 
proliferation and medicinal properties such 
as anti-inflammatory and 
immunomodulatory effects [24, 25]. 
Therefore, these cells provide a very useful 
source for cell therapy. Furthermore, 
paracrine influences are believed to be 
responsible for the therapeutic results of 
MSCs that have been shown to suppress not 
only internal organ fibrosis such as visceral 
fibrosis but also scaring and fibrosis of body 
surface tissues such as skin, processes 
indicated to be regulated by EMT [26-30]. 
In fact, various research have demonstrated 
the therapeutic effect of conditioned 
medium extracted from MSCs on recovery 
of accidents and autoimmune diseases [31]. 
Despite the mentioned points, the results of 
MSC and condition medium of MSC for 
cancer therapy are controversial. It has been 
proven that in cancer therapy, MSC has a 
dual role [32]. Nonetheless, recent research 
have reported contradictory findings about 
the stimulatory impact of MSCs on tumor 
pathogenesis by tumor micro-environmental 
help and tumor growth stimulation [33]. 
Mesenchymal stem cells-conditioned media 
(MSCs‐ CM) comprises a variety of factors 
generated and secreted by MSCs, such as 
Interleukin‐ 6 (IL‐ 6), CCl‐ 5, 
transforming beta growth factor and cell-
derived stromal factor‐ 1[34]. Researchers 
have revealed that MSCs-secreted factors 
including TWIST, MMP, WNT5A, and 
TGF-β stimulate tumor growth, progression, 
and metastasis, as opposed to antitumor 
impacts of MSCs [35]. Condition medium 
of mesenchymal stem cells from the 
umbilical cord tends to increase multiform 
glioblastoma cell proliferation and does not 
cause apoptosis [36]. The current study was 
performed as to investigate the effect of 
BMSC-CM in inducing EMT process in 
colorectal cancer cells. HT29 cells were 
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used for confirming whether BMSCs-CM 
can induce the EMT process. 
 
2. Materials and Methods 
2.1 Cell Culture 
     Colorectal cancer (CRC) cell lines were 
provided by Pasteur Institute of Iran-Tehran 
and cultured in RPMI-640, completed with 
10% fetal bovine serum (GIBCO) and 
100U/ml penicillin/streptomycin 
(Invitrogen, Carlsbad, CA, USA). Cells of 
CRC were incubated at 37°C with 
atmosphere humidity of 95%, 5% CO2 and 
95% O2.  
 
2.2 MSC Isolation and Culture  
     Human bone marrow mesenchymal stem 
cells were extracted from iliac crest 
biopsies. In brief, the bone marrow was 
extracted in an EDTA tube, and then, the 
buffy coat layer was isolated through 
centrifugation (450xg, 10min). The 
separated buffy-coat with an equivalent 
amount of Ficoll was centrifuged (400xg, 
20min) to obtain MSCs. The harvested cells 
were grown in a monolayer culture and 
preserved in a full medium of Dulbecco 
Enhanced Eagle Medium (DMEM, Gibco-
Invitrogen, USA), containing 15% Fetal 
Bovine Serum (FBS, Gibco-Invitrogen, 
USA) and 1% Penicillin / Streptomycin 
(Gibco-Invitrogen, USA) at 37°C and 5% 
CO2 in a humidified atmosphere. For the 
purpose of the present study, the bone 
marrow mesenchymal stem cells were used 
at passages 4-6. These cells were shown to 
be positive for flow-cytometry analysis of 
CD90, CD73 and negative CD34, and 
CD45 (all eBioscience, USA), and were 
able of form osteoplastic and adipogenic 
differentiation based on protocols 
developed (data haven't seen). Cell 
morphology modification was studied using 
contrast-phase microscopy (Olympus 
IX7071)[37]. 
 
2.3 Conditioned Media Preparation  
     BMSCs were washed twice with 
phosphate buffered saline (PBS) after 24 h 
of adherence to the flasks by the 3rd 
generation of BMSCs. The cells were then 
cultured with serum-free DMEM, and the 
supernatant (cells had achieved an 80 
percent confluence) was collected after 48h. 
The obtained supernatant was then 
centrifuged to 1,000rpm for 10min. The CM 
was collected with a sterile filter after the 
supernatants had been re-centrifuged at 
3,000rpm for 5min. 
 
2.4 BMSC-CM Treatment  
     After cells had reached to the confluence 
of about 80% in the T-25 flask, they are 
grown at a seeding density of 2x104/cm in 
two T-25 flasks. The seeded cells were fed 
through condition medium-MSC FBS free 
for 24 hours for the purpose of inducing 
EMT. Next, they replaced the medium with 
3ml MSC-condition medium treated for 48 
hours. After inducing EMT, cell alteration 
of morphology was studied with the use of 
contrast phase microscopy (Olympus 
IX7071).  
 
2.5 RNA Extraction and Real-Time 
Reverse Transcriptase-PCR 
     AllPrep DNA/RNA/miRNA Universal 
Kit (Qiagen, Hilden, Germany) was used as 
to extract RNA from CRC cell lines. The 
concentration and purification of extracted 
RNA were determined by using Nanodrop 
spectrophotometer (NanoDrop Techniques 
INC, USA). The reverse transcribed was 
used on 50ng of RNA. The Revert Aid First 
Strand cDNA Synthesis Kit (Thermo 
Scientific, USA) was used for that matter. 
The cDNA was provided for measuring the 
expression level of EMT biomarkers of 
ZEB1,E-cadherin, Vimentin, β-Catenin and 
Snail genes. GAPDH was used as an 
internal control in EMT array reaction. The 
Real-time PCR (PCR) was done in triplicate 
with SYBR Green Master Mix (Ampliqon, 
Denmark) on the Rotor-Gene 5plex HRM 
(QIAGEN, Hilden, Germany). Primers used 
in this study are shown in Table 1.  
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Table 1. Sequence of the primers used in the real-time PCR experiment  
Revers  Forward Gene names 
CTTCTCCGCCTCCTTCTTC TGCTCTTGCTGTTTCTTCGG E-cadherin 
GCATCGTATCACAGCAGGTT GGGTAGGGTAAATCAGTAAGAGGT β-catenin 
CGAAGGTGACGAGCCATT CCAGGCAAAGCAGGAGTC Vimentin 
TGCTGGAAGGTAAACTCTGGAT CACTATGCCGCGCTCTTTC Snail 
GGTTGGCAATACCGTCATCC  CAAGAGGCGCAAACAAGC ZEB1 
 
The expressions of the above genes were 
normalized to the housekeeping gene. The 
results were compared using the 2- ΔΔCT 
formula.  
 
2.6 Statistical Analysis 
     All analysis was done by the Excel and 
Graph Pad prism software. Each experiment 
was applied in three consecutive days and in 
duplicate. The results were determined as 
mean±SEM. Student’s T-test was used for 
analyzing differences between the two 
groups and one-way analysis of variance 
(ANOVA) was applied for analyzing more 
than two groups. Finally, the results of the 
acquired data proved to be statistically 
significant (p<0.05).  
 
3. Results 
Alteration of E-Cadherin, β-Catenin and 
Vimentin as Epithelial-Mesenchymal 
Transition (EMT) Markers by BMSCs-
CM in Colorectal Cancer Cells 
     The MSC-CM was prepared using 
human bone marrow isolated MSC. The 
impact of BMSCs-CM on human colorectal 
cancer HT29 cell line was tested. The 
majority of cell treatments with BMSCs-
CM gained a fibroblast spindle shape as 
shown in Fig.1. HT29 cell treatment with 
BMSCs-CM induced an EMT. E-cadherin, 
β-catenin and Vimentin are some of the 
markers related to EMT which have been 
tested in this study.  After BMSC-CM 
treated HT29, there were some changes in 
E-cadherin, β-catenin, and Vimentin. E-
cadherin is tested as a precursor of epithelial 
cells. On the other hand, modifications of β-
catenin and Vimentin are being investigated 
as receptors for mesenchyme cells. Real-
time PCR tests were used to determine their 
level of expression. This study manidested 
that relative to the control group, the level 
of expression in the epithelial cell marker, 
E-cadherin, decreased significantly 
(p=0.05). In comparison, mesenchyme cell 
markers, β-catenin and Vimentin showed 
substantial increase (β-catenin:0.01; 
vimentin:0.01) relative to the control group, 
indicating the transformation of epithelial 
cells into mesenchymal cells (EMT 




Figure 1. Changes in HT29 cells after treated with 48h and 72h BMSCs-CM observed with an invert microscope 
magnification of 200x 
HT29 HT29 BMSC-CM HT29 BMSC-CMCM 
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Figure 2. Real-time PCR analyzed the expression of E-cadherin, β-catenin, vimentin in colorectal cell line (HT29) with 
treated BMSC-CM compared to the HT29 without any treatment group. The expression of EMT markers were 
normalized by GAPDH as a housekeeping gene. Bar are indicting the MEAN +_SEM of three times experiments. Data 
represent significant decrease of E-cadherin (P=0.05) and increase of β-catenin (P=0.01), vimentin (P=0.01) after treated 
with BMSC-CM 
 
Increasing Transcription Factors of 
ZEB1 and Snail Associated with EMT 
Markers 
     EMT is characterized by downregulation 
of main epithelial markers (the most 
important being E-Cadherin) and 
upregulation of mesenchymal markers in 
order to show the influence of BMSCs-CM 
on the EMT process in the HT29 cell line. 
In this work, Real time-PCR analysis was 
used to test the degree of expression of 
ZEB1 and snail with EMT markers. Results 
revealed that the upregulation of ZEB1 and 
snail resulted in decreased expression of E-
Cadherin and increased expression of 
Vimentin and β-catenin in HT29 cell line. 
In other terms, after inducing EMT, ZEB1 
and snail (ZEB1:P=0.01; Snail:P=0.001) 














































Figure 3. ZEB1 and Snail expression levels in colorectal cell line analyzed with Real-time PCR. Both of these 
transcription factors enhanced after treated with BMSC-CM Snail (P=0.001), ZEB1(P= 0.01) the expression of 
transcription factors were normalaized by GAPDH as a housekeeping gene. Bars are indicting the MEAN +_SEM of 
three times experiments.  
 
4. Discussion 
     Colorectal cancer (CRC) is the third 
most prevalent cancer and the second 
leading cause of cancer-related deaths. 
Metastasis poses a medical threat to treating 
colorectal cancer [1]. In other words, 
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advanced metastasis CRC has no effective 
therapy [6]. In summary, it is necessary to 
identify new biomarkers for the diagnosis of 
CRC and to develop new methods of 
treatment [7].  
Various studies have demonstrated a close 
association between metastasis and the 
epithelial-mesenchymal transformation 
(EMT) phenomenon[9]. Phenotype was 
acquired by reducing epithelial marker 
expressions such as E-cadherin and 
mesenchymal (like Vimentin) [14]. Our 
assumption of a BMSC-CM has effect on 
inducing EMT in colorectal cancer. The 
results manifested that BMSC-CM induced 
EMT. It was also displayed that BMSC-CM 
contributed to morphological modification 
in cell line HT29; that is, to spindle-like 
cells, it alters the circular cells. Untreated 
HT29 cells in particular, had a clear 
epithelial morphology whereas HT29 
treated with BMSC-CM showed a 
mesenchymal shape, which is one of the 
characteristics of the EMT process. ZEB 
and Snail transcription factors regulate the 
EMT process, and the increase in the 
expression of these two factors results in a 
shift in the expression of the genes involved 
in the EMT process. The epithelial cell 
exhibits mesenchymal stem cell properties 
through lowering the E-cadherin level and 
increasing the amount of β-catenin and 
Vimentin. On the other hand, the molecular-
level studies indicated that the 
characteristics of stem cells in these cells 
are accompanied by β-catenin and increased 
Vimentin after BMSC-CM treatment and 
decreased E-cadherin after BMSC-CM 
treatment. EMT process relates to zinc-
finger factors such as Snail1, Snail2 (Slug), 
ZEB1/2 [15].  
Alternatively, activation by Snail factors of 
mesenchymal genes tends to be indirect, at 
least in part, by downregulation of E-
cadherin. On the other hand, ZEB factors 
include many separate domains for 
interaction with other transcriptional 
regulators reviewed previously [38]. ZEB1 
and ZEB2 cause an EMT through 
suppression of epithelial markers and 
mesenchymal activation [39-43] and were 
evaluated [44, 45]. The present study also 
suggests a significant increase in the level 
of the snail and ZEB1 transcription factors 
in the colorectal cancer cell line (HT29). 
This study shows that ZEB1 / Snail 
transcription factor activates an EMT 
through suppression of the epithelial marker 
and mesenchymal activation. Activation of 
mesenchymal genes by Snail influences 
seems indirect, at least partly, by 
downregulation of E-cadherin. With their 
inductive impact on ZEB1 and ZEB2, 
epithelial and mesenchymal markers are 
strictly controlled by Snail influences. 
On the other hand, Mesenchymal stem cells 
(MSCs) are adult stem cells which are 
readily isolated from postnatal tissues. 
MSCs also have replication capacities and 
therapeutic properties such as anti-
inflammatory and immunomodulatory 
activity [24, 25]. 
Numerous studies demonstrated that MSCs 
have inhibitory effects on tumor 
development by inhibiting angiogenesis, 
they suppress the immune responses [46-
49]. 
Despite all these, the results of MSC for 
cancer therapy are controversial. It has been 
proven that in cancer therapy, MSC has a 
double-edge role [32]. 
BM-MSCs were also found in another study 
to trigger the proliferation, migration and in 
vitro invasion of the prostate cell line PC3 
[50].  
Mesenchymal stem cells - conditioned 
media (MSCs‐ CM) comprise a multitude 
of elements generated and secreted by 
MSCs, such as Interleukin‐ 6 (IL‐ 6), 
CCl‐ 5, transforming the beta growth factor 
and the stromal factor‐ 1, derived from cells 
[34].  
Chuan et al. reported that melanoma cells 
induce EMT after being treated by MSC 
conditioned medium, and promote the 
migration and invasion which probably is 
associated with the TGF-β/Snail signaling 
pathway. And this was confirmed in a lung 
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metastasis mice model in vivo [51]. 
Isabele C, et al. demonstrate that 
Mesenchymal stem cell-conditioned 
medium induce Epithelial-to-Mesenchymal-
Like Transition in glioma cells [52]. 
There is a report from Xiaoyin, et al. that 
human umbilical cord MSC-CM plays a 
dual role in A549 lung cancer cells. This 
causes epithelial mesenchymal transition 
(EMT) and also induce invasion and 
migration of mentioned cells. MSC-CM 
promote cell apoptosis together with 
inhibition of cell proliferation [53]. 
Results showed HT29 cells associate with 
BMSC-CM. Also, results revealed that 
BMSC-CM has EMT-inducing ability 
which is probably related to paracrine 
secretion. This also plays a significant role 
in metastasis in the colorectal cancer cell 
line (HT29). The EMT model on colorectal 
cancer was typically caused by BMSC-CM. 
Real-time PCR examined cells in two 
experimental groups (HT29 cell with no 
treatment, HT29 cell with BMSC-CM 
treatment). Results demonstrated that EMT 
markers of β-catenin and Vimentin 
expressions were increased compared with 
HT29 cells with no treatment. However, E-
cadherin expression was decreased in HT29 
cell with no treatment. This research 
revealed that ZEB1 and Snail transcription 
factors are significant regulators of EMT 
through epithelial marker suppression and 
mesenchymal activation, and also establish 
an aggressive and metastatic condition in 
colorectal cancer.  
 
5. Conclusion 
     This model is used in order to 
understand the mechanism of cancer 
metastasis. Results pointed to 
morphological changes which derive from 
BMSC-CM, and could activate EMT 
induction. Furthermore, EMT markers of E-
cadherina, Vimentin, and β-Catenin are 
influenced by this process. This confirms 
that treatment of the cells with BMSCs-CM 
induces EMT by the overexpression of 
ZEB1and Snail genes. It indicates that the 
condition medium of BMSC induces EMT 
in the tumor micro-environment where it 
seems to be an interaction between EMT 
and paracrine secretion .Consequently, this 
study may also be utilized for drug 
screening procedures.   
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